Ontario Drug Benefit Formulary/Comparative Drug Index

Similar documents
Ontario Drug Benefit Formulary/ Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

UPDATE AA Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective September 15, 2011 SUMMARY OF CHANGES

UPDATE AF Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective March 26, 2012 SUMMARY OF CHANGES

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/ Comparative Drug Index

UPDATE C Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective November 04, 2008 SUMMARY OF CHANGES

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

UPDATE AJ Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective July 27, 2012 SUMMARY OF CHANGES

UPDATE AX Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective August 29, 2013 SUMMARY OF CHANGES

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index

UPDATE AU Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective May 31, 2013 SUMMARY OF CHANGES

UPDATE B Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 01, 2008 SUMMARY OF CHANGES

Ontario Drug Benefit Formulary/Comparative Drug Index

UPDATE E Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective December 23, 2008 SUMMARY OF CHANGES

UPDATE AB Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 25, 2011 SUMMARY OF CHANGES

Ontario Drug Benefit Formulary/Comparative Drug Index

UPDATE AZ Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 31, 2013 SUMMARY OF CHANGES

BULLETIN # 79. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 16, 2014

Ontario Drug Benefit Formulary/Comparative Drug Index

NB Drug Plans Formulary Update

UPDATE AE Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective February 29, 2012 SUMMARY OF CHANGES

SASKATCHEWAN FORMULARY BULLETIN Update to the 60th Edition of the Saskatchewan Formulary

BULLETIN # 78. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on July 17, 2014

UPDATE F Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective 30 January, 2009 SUMMARY OF CHANGES

NB Drug Plans Formulary Update

Ontario Drug Benefit Formulary/ Comparative Drug Index

BULLETIN # 74. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 17, 2013

Updates to the Alberta Drug Benefit List. Effective August 1, 2014

UPDATE C Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective November 04, 2008 SUMMARY OF CHANGES

NB Drug Plans Formulary Update

Ontario Drug Benefit Formulary/Comparative Drug Index

20:00. Blood Formulation, Coagulation and Thrombosis. 20:00 Blood Formulation, Coagulation and Thrombosis

BULLETIN # 84. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 22, 2015

NB Drug Plans Formulary Update

New Interchangeable Products Approved and Benefit Status Within the Nova Scotia Pharmacare Programs March 2016

BULLETIN # 80. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 19, 2015

Updates to the Alberta Health and Wellness Drug Benefit List

New Exception Status Benefits

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN FOR THE UPDATE TO THE 56th EDITION OF THE SASKATCHEWAN FORMULARY

SASKATCHEWAN FORMULARY BULLETIN. Update to the 60th Edition of the Saskatchewan Formulary

Alberta Human Services Drug Benefit Supplement

UPDATE Z Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective August 04, 2011 SUMMARY OF CHANGES

Product Selection Committee / Comité de sélection des produits

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN UPDATE TO THE 57th EDITION OF THE SASKATCHEWAN FORMULARY

SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN TO THE 55th EDITION OF THE SASKATCHEWAN FORMULARY

Updates to the Alberta Drug Benefit List. Effective February 1, 2018

BULLETIN # 89. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 20, 2016

Manager, PEI Drug Programs Date : December 7, 2009 Tel / Tél : (902) Fax / Téléc : (902)

Updates to the Alberta Drug Benefit List. Effective November 1, 2018

Updates to the Alberta Drug Benefit List. Effective June 1, 2018

NBPDP Formulary Update

Updates to the Alberta Drug Benefit List. Effective October 1, 2017

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN TO THE 58th EDITION OF THE SASKATCHEWAN FORMULARY

Nova Scotia Pharmacare Programs Interchangeable Product Updates November 13, 2018 New Categories

Pharmacy Consultant, PEI Drug Programs Date : September 8, 2009 Tel / Tél : (902) Fax / Téléc : (902)

Therapeutic Substitution Service - Proton Pump Inhibitors (PPIs)

BULLETIN # 65. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 14, 2010.

Non-Insured Health Benefits

BULLETIN # 73. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on July 17, 2013

Updates to the Alberta Drug Benefit List. Effective December 1, 2018

BULLETIN # 90. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 25, 2017

BULLETIN # 50. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on March 13, 2006.

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN 55th EDITION

Palliative Coverage Drug Benefit Supplement

Updates to the Alberta Drug Benefit List. Effective July 1, 2017

BENEFIT CHANGES TO NBPDP

NBPDP FORMULARY UPDATE

SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN 52nd Edition

Updates to the Alberta Drug Benefit List. Effective May 1, 2018

New Exception Status Benefits

NB Drug Plans Formulary Update

NB Drug Plans Formulary Update

Updates to the Alberta Drug Benefit List. Effective July 1, 2018

BULLETIN # 101. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 18, 2018

BULLETIN # 70. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 21, 2013

SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN TO THE 55th EDITION OF THE SASKATCHEWAN FORMULARY

Prescriber Validation

Ministry of Health. BC Chronic Disease and Selected Procedure Case Definitions. Chronic Disease Information Working Group. Date Created: June 29, 2015

Archived Content. This content was archived on June 24, 2013.

PEI Drug Programs. Issue October, 2006

UPDATE AT Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective April 30, 2013 SUMMARY OF CHANGES

SUMMARY OF CHANGES. UPDATE 3 Ontario Drug Benefit Formulary/Comparative Drug Index No. 40 Effective July 12, 2007 TABLE OF CONTENTS.

Updates to the Alberta Human Services Drug Benefit Supplement

Product Selection Committee / Comité de sélection des produits

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN UPDATE TO THE 54th EDITION

Transcription:

Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - July 2014 Effective July 30, 2014 Ministry of Health and Long-Term Care

Table of Contents New Single Source Products... 3 New Multi-Source Products... 4 New Off-Formulary Interchangeable (OFI) Products... 10 Drug Benefit Price (DBP) Changes... 11 Product Brand and Manufacturer Name Changes... 12 Status Change from General Benefit to Not-A-Benefit... 13 Removal of Therapeutic Note... 14 Discontinued Products... 15 Delisted Products... 16 2

New Single Source Products DIN PRODUCT NAME GENERIC NAME MFR DBP 02412829 Levemir Flextouch 100U/mL Inj Sol-Pref Disp Pen 5 X 3mL Pk Insulin Detemir NOO 106.7600 3

New Multi-Source Products 02372738 Apo-Mycophenolic Acid 180mg Ent Tab APX 1.4983 02372746 Apo-Mycophenolic Acid 360mg Ent Tab APX 2.9965 (Interchangeable with Myfortic) 02423642 Auro-Losartan HCT 50mg & 12.5mg Tab AUR 0.3147 (Interchangeable with Hyzaar ) 02406853 Fondaparinux Sodium Injection (Interchangeable with Arixtra) 2.5mg/0.5mL Reason For Use Code & Clinical Criteria Code 378 Inj Sol-Pref Syr 0.5mL Pk DRR 11.1944 For the post-operative prophylaxis of venous thromboembolic events in patients undergoing orthopedic surgery of the lower limbs such as hip fracture, hip replacement or knee surgery. NOTE: Limited to 9 days of reimbursement. LU Authorization Period: 1 year. 4

New Multi-Source Products (Cont d...) 02415550 Jamp-Clopidogrel 75mg Tab JPC 0.6576 (Interchangeable with Plavix) 02423553 Mint-Ciproflox 250mg Tab MIN 0.6186 02423561 Mint-Ciproflox 500mg Tab MIN 0.6979 02423588 Mint-Ciproflox 750mg Tab MIN 1.2780 (Interchangeable with Cipro) Reason For Use Code & Clinical Criteria For the treatment of patients with: Code 332 SST/BJ (Gram negative bacteria): Skin/soft tissue and bone/joint infection due to gram negative bacteria; severe diabetic foot infection; severe otitis externa; decubitus ulcers. LU Authorization Period: 1 year. Code 333 GU Tract: Urinary tract infection/prostatitis/epididymitis caused by (suspected or documented) Pseudomonas; sexually transmitted diseases. LU Authorization Period: 1 year. Continued on next page. 5

. Continued from previous page Reason For Use Code & Clinical Criteria Code 334 COPD with risk: Acute bacterial exacerbation of chronic obstructive pulmonary disease (COPD) with risk factors*; bronchiectasis; pneumonic illness with cystic fibrosis. *Risk factors include: poor pulmonary lung function (FEV1 below 50% predicted level), age over 65 years, co-morbid medical illness (congestive heart failure, diabetes, chronic renal failure, chronic liver disease), chronic corticosteroid use, malnutrition, prolonged duration of disease or 4 or more exacerbations per year. LU Authorization Period: 1 year. Code 336 Step-Down: Step-down therapy after parenteral therapy or hospital/emergency department discharge; febrile neutropenia. LU Authorization Period: 1 year. Code 350 GI: Traveller's diarrhea; enteric fever syndromes; Crohn's disease. LU Authorization Period: 1 year. Code 353 For the prophylaxis or treatment of B. anthracis exposure. LU Authorization Period: 1 year. Code 977 Exceptional cases of allergy or intolerance to all other appropriate therapies. LU Authorization Period: 1 year. 6

New Multi-Source Products (Cont d...) 02392933 Mylan-Atorvastatin 10mg Tab MYL 0.3138 02392941 Mylan-Atorvastatin 20mg Tab MYL 0.3922 02392968 Mylan-Atorvastatin 40mg Tab MYL 0.4216 02392976 Mylan-Atorvastatin 80mg Tab MYL 0.4216 (Interchangeable with Lipitor) 02424177 PMS-Risedronate 150mg Tab PMS 11.1875 (Interchangeable with Actonel) 02417340 Sandoz Candesartan 32mg Tab SDZ 0.2932 (Interchangeable with Atacand) 02420732 Sandoz Candesartan Plus 32mg & 12.5mg Tab SDZ 0.3008 02420740 Sandoz Candesartan Plus 32mg & 25mg Tab SDZ 0.3008 (Interchangeable with Atacand Plus) 7

New Multi-Source Products (Cont d...) 02316307 Sandoz Dorzolamide 2% Oph Sol SDZ 3.0700 (Interchangeable with Trusopt) Reason For Use Code & Clinical Criteria Code 171 As first line treatment of elevated intraocular pressure in patients who cannot tolerate an ophthalmic beta-blocking agent or where beta-blocking agents are contraindicated; LU Authorization Period: Indefinite. Code 172 As second line monotherapy or combination therapy in patients who do not have an adequate intraocular pressure lowering response to ophthalmic beta-blocking agents. LU Authorization Period: Indefinite. Code 387 For use as adjunctive therapy with an ophthalmic beta-blocking agent in an urgent situation (e.g. patients with a high baseline intraocular pressure) where monotherapy is unlikely to be effective.. LU Authorization Period: Indefinite. 8

New Multi-Source Products (Cont d...) 02344351 Sandoz Dorzolamide/Timolol 2% & 0.5% Oph Sol SDZ 2.0951 (Interchangeable with Cosopt) Reason For Use Code Clinical Criteria Code 310 As second-line therapy for patients who do not have an adequate intraocular pressure lowering response to monotherapy with ophthalmic beta-blocking agents. LU Authorization Period: Indefinite. Code 393 For use as initial therapy in an urgent situation (e.g. patients with a high baseline intraocular pressure) where monotherapy is unlikely to be effective. LU Authorization Period: Indefinite. 02407515 Taro-Carbamazepine 200mg Tab TAR 0.1540 (Interchangeable with Tegretol) 02266385 Taro-Mometasone 0.1% Lot TAR 0.3358 (Interchangeable with Elocom) 02401967 Tricira Lo (21 Day) 3 Phase Tab-21 Pk APX 9.4725 02401975 Tricira Lo (28 Day) 3 Phase Tab-28 Pk APX 9.4725 (Interchangeable with Tri-Cyclen Lo) 9

New Off-Formulary Interchangeable (OFI) Products DIN BRAND NAME STRENGTH DOSAGE FORM MFR UNIT COST 02414805 Abbott-Levetiracetam 250mg Tab ABB 1.1175 02414791 Abbott-Levetiracetam 500mg Tab ABB 1.3650 02414783 Abbott-Levetiracetam 750mg Tab ABB 1.9425 (Interchangeable with Keppra ) DIN BRAND NAME STRENGTH DOSAGE FORM MFR UNIT COST 02406896 Fondaparinux Sodium Injection (Interchangeable with Arixtra) 7.5mg/0.6mL Inj Sol-Pref Syr 0.6mL Pk DRR 18.1356 DIN BRAND NAME STRENGTH DOSAGE FORM MFR UNIT COST 02421623 Jamp-Zolmitriptan 2.5mg Tab JPC 6.8583 (Interchangeable with Zomig) 10

Drug Benefit Price (DBP) Changes 02377721 Apo-Risedronate 150mg Tab APX 11.1875 02377454 Fragmin 2500IU/mL Single Dose-4mL Vial Pk PFI 16.8790 02403633 Teva- Alendronate/Cholecalciferol 02403641 Teva- Alendronate/Cholecalciferol 70mg & 70mcg Tab TEV 3.4969 70mg & 140mcg Tab TEV 3.4969 11

Product Brand and Manufacturer Name Changes DIN CURRENT BRAND NAME CURRENT MFR NEW BRAND NAME NEW MFR STRENGTH DOSAGE FORM 02247008 Novo-Pravastatin NOP Teva-Pravastatin TEV 10mg Tab 02247009 Novo-Pravastatin NOP Teva-Pravastatin TEV 20mg Tab 02247010 Novo-Pravastatin NOP Teva-Pravastatin TEV 40mg Tab 12

Status Change from General Benefit to Not-A-Benefit DIN BRAND NAME STRENGTH DOSAGE FORM MFR 00789747 Prochlorperazine Mesylate 10mg/2mL Inj Sol-2mL Pk SDZ (Interchangeable with Stemetil) 13

Removal of Therapeutic Note The following Therapeutic Note is removed from Pharmacologic-Therapeutic Classification 84:04:12 ANTI-INFECTIVES PARASITICIDES: Therapeutic Note All close contacts of patients with scabies should be treated regardless of symptoms to avoid reinfestation and unnecessary repeated treatments. The scabicide should be applied to all the skin from the neck down. Young children, the elderly and immunosuppressed patients may also require treatment of the head and scalp. 14

Discontinued Products (Some products will remain on Formulary for six months to facilitate depletion of supply) DIN/PIN BRAND NAME STRENGTH DOSAGE FORM MFR 02231379 Anzemet 100mg Tab SAV 97982580 Boost 1.0 Standard 1.06kcal/mL Liq-237mL Pk NES 02318008 Travatan Z 0.004% Oph Sol-2.5mL Pk ALC 02224690* Lasix 20mg Tab SAV 02224704* Lasix 40mg Tab SAV *Remain in Formulary as Not-a-Benefit to serve as reference product in interchangeable group. 15

Delisted Products DIN/PIN BRAND NAME STRENGTH DOSAGE FORM MFR 00396796 Apo-Haloperidol 0.5mg Tab APX 00663719 Apo-Propranolol 20mg Tab APX 97983250 Caloreen Pd 1kg Pk NES 97980390 Caloreen Pd 5kg Pk NES 02332027 Cefprozil Powder for Oral Suspension 250mg/5mL-75mL Pk Oral Susp RAN 09857366 Cefprozil Powder for Oral Suspension 250mg/5mL-100mL Pk Oral Susp RAN 01997653 Dantrium 100mg Cap JHP 09857353 Humalog Mix25 Kwikpen 25% & 75% Inj Susp-5X3mL Pk LIL 09857437 Midazolam Injection 5mg/mL Inj Sol-2mL Vial Pk PPC 09853529 NuBasic Liq-250mL Pk NES 09853537 NuBasic Plus Liq-250mL Pk NES 09853561 NuBasic VHP Liq-250mL Pk NES 97984671 Nutren 1.0 1kcal/mL Liq-250mL Pk NES 02313448 PMS-Atorvastatin 10mg Tab PMS 02253933 PMS-Ciprofloxacin 0.003 Oph Sol-5mL Pk PMS 02273551 PMS-Fenofibrate Micro 200mg Cap PMS 02240682 PMS-Fluvoxamine 50mg Tab PMS 02240683 PMS-Fluvoxamine 100mg Tab PMS 02252570 PMS-Ofloxacin 0.3% Oph Sol PMS 02240363 PMS-Polytrimethoprim 10000U/mL & 1mg/mL Oph Sol-10mL Pk PMS 02239577 PMS-Tobramycin 0.3% Oph Sol PMS 00621447 Sandoz Anuzinc 0.5% Oint SDZ 02245456 Sandoz Aurothiomalate 10mg/mL Inj Sol-1mL Pk SDZ 02245457 Sandoz Aurothiomalate 25mg/mL Inj Sol-1mL Pk SDZ 02261855 Sandoz Carbamazepine Chewtabs 100mg Chew Tab SDZ 02233960 Sandoz Clonazepam 0.5mg Tab SDZ 02257564 Sandoz Loperamide 2mg Caplet SDZ 02234003 Sandoz Nitrazepam 5mg Tab SDZ 02234007 Sandoz Nitrazepam 10mg Tab SDZ 02261782 Sandoz Pindolol 5mg Tab SDZ 02261790 Sandoz Pindolol 10mg Tab SDZ 16

Delisted Products (Cont d...) DIN/PIN BRAND NAME STRENGTH DOSAGE FORM MFR 02247856 Sandoz Pravastatin 10mg Tab SDZ 02247857 Sandoz Pravastatin 20mg Tab SDZ 02247828 Sandoz Simvastatin 10mg Tab SDZ 02247830 Sandoz Simvastatin 20mg Tab SDZ 02247831 Sandoz Simvastatin 40mg Tab SDZ 02247833 Sandoz Simvastatin 80mg Tab SDZ 02331969 Simvastatin Tablets 5mg Tab RAN 02331985 Simvastatin Tablets 10mg Tab RAN 02331993 Simvastatin Tablets 20mg Tab RAN 02332000 Simvastatin Tablets 40mg Tab RAN 02332019 Simvastatin Tablets 80mg Tab RAN 17

ISSN 1916-2278 (PDF) July 2014 Queen s Printer for Ontario, 2014.